Objective
During my ERC starting grant project, my lab has identified small molecule inhibitors that inhibit the proliferation of MYB-dependent leukemia cell lines. In this proof of concept project, we aim to investigate the potential of these compounds to be further developed as anti-cancer agents. We will determine their potential to inhibit the proliferation breast cancer and colon cancer cell lines and possible additional activity against other solid tumors. In addition, we will investigate the IP landscape and possibilities to improve the chemical properties. These pre-clinical data should provide the basis for the further development of these MYB inhibitors as anti-cancer agents.
Field of science
- /medical and health sciences/clinical medicine/cancer/colorectal cancer
- /medical and health sciences/clinical medicine/cancer/breast cancer
Call for proposal
ERC-2011-PoC
See other projects for this call
Funding Scheme
CSA-SA(POC) - Supporting action (Proof of Concept)Host institution
9052 Zwijnaarde - Gent
Belgium
Beneficiaries (1)
9052 Zwijnaarde - Gent